{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:48:29Z","timestamp":1791402509919,"version":"4.3.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,5,24]],"date-time":"2009-05-24T00:00:00Z","timestamp":1243123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/nm.1968","type":"journal-article","created":{"date-parts":[[2009,5,24]],"date-time":"2009-05-24T14:06:47Z","timestamp":1243174007000},"page":"633-640","source":"Crossref","is-referenced-by-count":513,"title":["Prostaglandin E2\u2013EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion"],"prefix":"10.1038","volume":"15","author":[{"given":"Chengcan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiji","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuh","family":"Narumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,24]]},"reference":[{"key":"BFnm1968_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","author":"L Steinman","year":"2007","unstructured":"Steinman, L. A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell\u2013mediated tissue damage. Nat. Med. 13, 139\u2013145 (2007).","journal-title":"Nat. Med."},{"key":"BFnm1968_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and TH17 cells. Annu. Rev. Immunol. 27, 485\u2013517 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm1968_CR3","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1084\/jem.20072066","volume":"205","author":"L Steinman","year":"2008","unstructured":"Steinman, L. A rush to judgment on TH17. J. Exp. Med. 205, 1517\u20131522 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnm1968_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1132","volume":"3","author":"G Bouma","year":"2003","unstructured":"Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521\u2013533 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1968_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes, M.A., Bowcock, A.M. & Krueger, J.G. Pathogenesis and therapy of psoriasis. Nature 445, 866\u2013873 (2007).","journal-title":"Nature"},{"key":"BFnm1968_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm0502-500","volume":"8","author":"C Lock","year":"2002","unstructured":"Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500\u2013508 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1968_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos, J.S. et al. Interleukin-17 produciton in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146\u2013155 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFnm1968_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0165-5728(03)00221-2","volume":"141","author":"IR Moldovan","year":"2003","unstructured":"Moldovan, I.R. et al. Interferon \u03b3 responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression. J. Neuroimmunol. 141, 132\u2013140 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnm1968_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/WNL.51.3.753","volume":"51","author":"K Fassbender","year":"1998","unstructured":"Fassbender, K. et al. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 51, 753\u2013758 (1998).","journal-title":"Neurology"},{"key":"BFnm1968_CR10","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","volume":"164","author":"M Ziolkowska","year":"2000","unstructured":"Ziolkowska, M. et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A\u2013sensitive mechanism. J. Immunol. 164, 2832\u20132838 (2000).","journal-title":"J. Immunol."},{"key":"BFnm1968_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65\u201370 (2003).","journal-title":"Gut"},{"key":"BFnm1968_CR12","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato, F. et al. Phenotypic and functional feature of human TH17 cells. J. Exp. Med. 204, 1849\u20131861 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnm1968_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes, M.A. et al. Psoriasis vulgaris lesions contain discrete populations of TH1 and TH17 T cells. J. Invest. Dermatol. 128, 1207\u20131211 (2008).","journal-title":"J. Invest. Dermatol."},{"key":"BFnm1968_CR14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr, R.H. et al. A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science 314, 1461\u20131463 (2006).","journal-title":"Science"},{"key":"BFnm1968_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427\u2013434 (2007).","journal-title":"Nature"},{"key":"BFnm1968_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","volume":"122","author":"F Capon","year":"2007","unstructured":"Capon, F. et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122, 201\u2013206 (2007).","journal-title":"Hum. Genet."},{"key":"BFnm1968_CR17","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa033402","volume":"351","author":"PJ Mannon","year":"2004","unstructured":"Mannon, P.J. et al. Anti\u2013interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351, 2069\u20132079 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1968_CR18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa062382","volume":"356","author":"GG Krueger","year":"2007","unstructured":"Krueger, G.G. et al. A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580\u2013592 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1968_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2183\/pjab.83.296","volume":"83","author":"S Narumiya","year":"2007","unstructured":"Narumiya, S. Physiology and pathophysiology of prostanoid receptors. Proc. Japan Acad. Ser. B. 83, 296\u2013319 (2007).","journal-title":"Proc. Japan Acad. Ser. B."},{"key":"BFnm1968_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00915791","volume":"3","author":"JS Goodwin","year":"1983","unstructured":"Goodwin, J.S. & Ceuppens, J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 3, 295\u2013315 (1983).","journal-title":"J. Clin. Immunol."},{"key":"BFnm1968_CR21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.131.2.768","volume":"131","author":"F Hasler","year":"1983","unstructured":"Hasler, F., Bluestein, H.G., Zvaifler, N.J. & Epstein, L.B. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J. Immunol. 131, 768\u2013772 (1983).","journal-title":"J. Immunol."},{"key":"BFnm1968_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.146.1.108","volume":"146","author":"M Betz","year":"1991","unstructured":"Betz, M. & Fox, B.S. Prostaglandin E2 inhibits production of TH1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108\u2013113 (1991).","journal-title":"J. Immunol."},{"key":"BFnm1968_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/art.1780370623","volume":"37","author":"KN Gold","year":"1994","unstructured":"Gold, K.N., Weyand, C.M. & Goronzy, J.J. Modulation of helper T cell function by prostaglandins. Arthritis Rheum. 37, 925\u2013933 (1994).","journal-title":"Arthritis Rheum."},{"key":"BFnm1968_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/eji.1830250112","volume":"25","author":"CM Hilkens","year":"1995","unstructured":"Hilkens, C.M. et al. Differential modulation of T helper type 1 (TH1) and T helper type 2 (TH2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25, 59\u201363 (1995).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1968_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","volume":"23","author":"SG Harris","year":"2002","unstructured":"Harris, S.G., Padilla, J., Koumas, L., Ray, D. & Phipps, R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23, 144\u2013150 (2002).","journal-title":"Trends Immunol."},{"key":"BFnm1968_CR26","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto, Y. & Narumiya, S. Prostaglandin E receptors. J. Biol. Chem. 282, 11613\u201311617 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnm1968_CR27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1172\/JCI200113640","volume":"108","author":"C Nataraj","year":"2001","unstructured":"Nataraj, C. et al. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229\u20131235 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm1968_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bj20021637","volume":"371","author":"T Mustelin","year":"2003","unstructured":"Mustelin, T. & Tasken, K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371, 15\u201327 (2003).","journal-title":"Biochem. J."},{"key":"BFnm1968_CR29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1158\/0008-5472.CAN-05-3252","volume":"66","author":"JM Chemnitz","year":"2006","unstructured":"Chemnitz, J.M. et al. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66, 1114\u20131122 (2006).","journal-title":"Cancer Res."},{"key":"BFnm1968_CR30","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/endo.141.4.7405","volume":"141","author":"T Suzawa","year":"2000","unstructured":"Suzawa, T. et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3 and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141, 1554\u20131559 (2000).","journal-title":"Endocrinology"},{"key":"BFnm1968_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI200113455","volume":"108","author":"S Narumiya","year":"2001","unstructured":"Narumiya, S. & FiztGerald, G.A. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108, 25\u201330 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm1968_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI0214459","volume":"109","author":"K Kabashima","year":"2002","unstructured":"Kabashima, K. et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883\u2013893 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnm1968_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/bbrc.1998.8461","volume":"246","author":"E Segi","year":"1998","unstructured":"Segi, E. et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4\u2013deficient mice. Biochem. Biophys. Res. Commun. 246, 7\u201312 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm1968_CR34","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.1073\/pnas.96.18.10501","volume":"96","author":"H Hizaki","year":"1999","unstructured":"Hizaki, H. et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2 . Proc. Natl. Acad. Sci. USA 96, 10501\u201310506 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1968_CR35","doi-asserted-by":"publisher","first-page":"35394","DOI":"10.1074\/jbc.M302179200","volume":"278","author":"AE Christensen","year":"2003","unstructured":"Christensen, A.E. et al. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394\u201335402 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1968_CR36","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.122re4","volume":"1","author":"AJ Murray","year":"2008","unstructured":"Murray, A.J. Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal. 1, re4 (2008).","journal-title":"Sci. Signal."},{"key":"BFnm1968_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0955-0674(96)80060-3","volume":"8","author":"CL Carpenter","year":"1996","unstructured":"Carpenter, C.L. & Cantley, L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8, 153\u2013158 (1996).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnm1968_CR38","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1073\/pnas.0510562103","volume":"103","author":"FG Buchanan","year":"2006","unstructured":"Buchanan, F.G. et al. Role of \u03b2-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. USA 103, 1492\u20131497 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1968_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lfs.2003.09.031","volume":"74","author":"JW Regan","year":"2003","unstructured":"Regan, J.W. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74, 143\u2013153 (2003).","journal-title":"Life Sci."},{"key":"BFnm1968_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nri1056","volume":"3","author":"K Okkenhaug","year":"2003","unstructured":"Okkenhaug, K. & Vanhaesebroeck, B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3, 317\u2013330 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1968_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233\u2013240 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1968_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","volume":"30","author":"YK Lee","year":"2009","unstructured":"Lee, Y.K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92\u2013107 (2009).","journal-title":"Immunity"},{"key":"BFnm1968_CR43","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.4049\/jimmunol.0803931","volume":"182","author":"R Nurieva","year":"2009","unstructured":"Nurieva, R., Yang, X.O., Chung, Y. & Dong, C. Cutting edge: In vitro generated TH17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J. Immunol. 182, 2565\u20132568 (2009).","journal-title":"J. Immunol."},{"key":"BFnm1968_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","volume":"17","author":"S Nakae","year":"2002","unstructured":"Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17\u2013deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375\u2013387 (2002).","journal-title":"Immunity"},{"key":"BFnm1968_CR45","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1073\/pnas.0802218105","volume":"105","author":"S Serada","year":"2008","unstructured":"Serada, S. et al. IL-6 blockade inhibits the induction of myelin antigen\u2013specific TH17 cells and TH1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105, 9041\u20139046 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1968_CR46","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nm872","volume":"9","author":"K Kabashima","year":"2003","unstructured":"Kabashima, K. et al. Prostaglandin E2\u2013EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9, 744\u2013749 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1968_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"BFnm1968_CR48","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.4049\/jimmunol.178.12.8138","volume":"178","author":"AF Sheibanie","year":"2007","unstructured":"Sheibanie, A.F. et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23 \u2192 IL-17 axis. J. Immunol. 178, 8138\u20138147 (2007).","journal-title":"J. Immunol."},{"key":"BFnm1968_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.181.1.721","volume":"181","author":"T Khayrullina","year":"2008","unstructured":"Khayrullina, T., Yen, J.H., Jing, H. & Ganea, D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12\/IL-23 balance and promotes differentiation of TH17 cells. J. Immunol. 181, 721\u2013735 (2008).","journal-title":"J. Immunol."},{"key":"BFnm1968_CR50","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1084\/jem.20070773","volume":"204","author":"M Nagamachi","year":"2007","unstructured":"Nagamachi, M. et al. Facilitation of TH1-mediated immune response by prostaglandin E receptor EP1. J. Exp. Med. 204, 2865\u20132874 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnm1968_CR51","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.tibs.2006.10.002","volume":"31","author":"JL Bos","year":"2006","unstructured":"Bos, J.L. Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31, 680\u2013686 (2006).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm1968_CR52","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1371\/journal.pgen.0030058","volume":"3","author":"C Libioulle","year":"2007","unstructured":"Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).","journal-title":"PLoS Genet."},{"key":"BFnm1968_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nm0107-26","volume":"13","author":"MF Neurath","year":"2007","unstructured":"Neurath, M.F. IL-23: a master regulator in Crohn disease. Nat. Med. 13, 26\u201328 (2007).","journal-title":"Nat. Med."},{"key":"BFnm1968_CR54","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/eji.200324143","volume":"33","author":"M Herv\u00e9","year":"2003","unstructured":"Herv\u00e9, M. et al. Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur. J. Immunol. 33, 2764\u20132772 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1968_CR55","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ni943","volume":"4","author":"K Kabashima","year":"2003","unstructured":"Kabashima, K. et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4, 694\u2013701 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnm1968_CR56","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1182\/blood-2008-05-155408","volume":"112","author":"C Chizzolini","year":"2008","unstructured":"Chizzolini, C. et al. Prostaglandin E2 synergistically with interleukin-23 favors human TH17 expansion. Blood 112, 3696\u20133703 (2008).","journal-title":"Blood"},{"key":"BFnm1968_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20082293","volume":"206","author":"K Boniface","year":"2009","unstructured":"Boniface, K. et al. Prostaglandin E2 regulates TH17 cell differentiation and function through cyclic AMP and EP2\/EP4 receptor signaling. J. Exp. Med. 206, 535\u2013548 (2009).","journal-title":"J. Exp. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.1968.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1968","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1968.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T05:17:20Z","timestamp":1684991840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,24]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnm1968"],"URL":"https:\/\/doi.org\/10.1038\/nm.1968","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1161121.621591","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,24]]}}}